Senate "BioShield II" Hearing To Discuss Manufacturer Liability, Development Incentives
This article was originally published in The Pink Sheet Daily
Executive Summary
Joint Health-Judiciary Committee hearing Oct. 6 will review additional incentives for pharmaceutical and biotech firms to develop medical countermeasures for bioterrorism-related threats.